Home
Scholarly Works
Rapamycin Treatment Endows Car-engineered...
Conference

Rapamycin Treatment Endows Car-engineered CD8+Effector T Cells With Memory-like Properties Resulting in Enhanced in vivo Engraftment

Authors

Hammill JA; VanSeggelen H; Bassett JD; Nolte S; Denisova GF; Evelegh C; Rabinovich B; Bramson JL

Volume

35

Pagination

pp. 764-764

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

November 1, 2012

Name of conference

27th Annual Scientific Meeting of the Society-for-Immunotherapy-of-Cancer (SITC)

Conference place

North Bethesda, MD

Conference start date

October 24, 2012

Conference end date

October 28, 2012

Conference proceedings

JOURNAL OF IMMUNOTHERAPY

Issue

9

ISSN

1524-9557

Contact the Experts team